Menarini markets Vanguard's frovatriptan in Europe
Private Italian pharmaceutical company Menarini will market Vanguard Medica's frovatriptan in Europe. The drug, a 5HT 1B/1D agonist, is used to treat migraine headaches.
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.